drugset / Trial / NCT02222324
A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
This thorough QT (TQT) study will take place in healthy subjects administered single doses of study drug. It will be a randomized, double-blind, placebo and active-controlled, 4-treatment crossover study. Subjects will be randomized in an equal ratio to one of 12 possible treatment sequences. Each treatment sequence will comprise all 4 treatments.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elenbecestat | Small molecule | — | — |
| Comparator | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.